{"id":"W4389608093","doi":"10.1016/s1470-2045(23)00539-9","title":"Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study","year":2023,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"National Health and Medical Research Council; F. Hoffmann-La Roche; Roche","keywords":"Atezolizumab; Metastatic Urothelial Carcinoma; Medicine; Placebo; Internal medicine; Oncology; Chemotherapy; Cancer; Bladder cancer; Pembrolizumab; Immunotherapy; Urothelial carcinoma; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008615688,0.0004662331,0.00285071,0.000376489,0.0001262969,0.00003384868,0.0003584333,0.0001312384,0.001215115],"category_scores_gemma":[0.0001561121,0.0002752646,0.0004219576,0.001382341,0.0001425716,0.0000741269,0.00004649275,0.000373261,0.000101499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000462113,"about_ca_system_score_gemma":0.0006945936,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00358926,"about_ca_topic_score_gemma":0.004679072,"domain_scores_codex":[0.9963353,0.001056887,0.0007646646,0.0006563675,0.0004486718,0.0007381411],"domain_scores_gemma":[0.9970602,0.001646424,0.0002636484,0.0007655704,0.0001065127,0.0001575981],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9473216,0.002941849,0.01335974,0.00001477242,0.009385383,0.001624234,0.003328834,0.0005975327,0.0008201215,0.00002141407,0.0003609393,0.0202236],"study_design_scores_gemma":[0.9375986,0.01098908,0.03852477,0.0000184264,0.004002979,0.00001130192,0.001186481,0.005126779,0.0002213665,0.0001614842,0.001866886,0.0002917805],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896032,0.0003653849,0.0002034613,0.003072015,0.0004688006,0.004841425,0.0001983072,0.0001803931,0.001066998],"genre_scores_gemma":[0.9946878,0.0006990848,0.0002208333,0.001262284,0.000495458,0.00129743,0.0001840208,0.00006883615,0.001084266],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02516502,"threshold_uncertainty_score":0.99997,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09030359634918199,"score_gpt":0.3988979223683898,"score_spread":0.3085943260192078,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}